BROSSARD, QUÉBEC–(Marketwired – Feb. 14, 2017) – DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX VENTURE:ADK), is pleased to announce a three-month contract extension to the successful pilot screening program with an organization of the Mexican government which ended December 31st, 2016. During the trial period, a total of close to 70,000 diabetic patients were screened using DIAGNOS’ CARA Artificial Intelligence tool and the three-month contract extension will bring the total number of patients screened to close to 106,300 at March 31st, 2017. The contract was initially announced on June 8th, 2016. Negotiations are well underway for a two-year national coverage contract expansion with the same organization.
